Market Overview:
The global Haemophilus influenzae nucleic acid detection kit market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of Haemophilus influenzae infections, rising demand for rapid and accurate diagnosis, and technological advancements in nucleic acid detection kits. Based on type, the global haemophilus influenzae nucleic acid detection kit market is segmented into dry PCR and fluorescence PCR. The fluorescence PCR segment is expected to grow at a higher CAGR than the dry PCR segment during the forecast period. This can be attributed to its advantages such as high sensitivity and specificity, ability to detect low-level targets, and short turnaround time. Based on application, the global haemophilus influenzae nucleic acid detection kit market is divided into hospital laboratories and clinic laboratories.
Product Definition:
The Haemophilus influenzae Nucleic Acid Detection Kit is a molecular diagnostic assay used to detect the presence of nucleic acid from Haemophilus influenzae in clinical specimens. The kit is used as an aid in the diagnosis of H. influenzae infections, including meningitis, pneumonia, and septicemia.
Dry PCR:
Dry PCR, also known as liquid-based PCR (L-BPP), is a new and innovative approach to detect nucleic acid. It involves the use of small sample volumes and does not require any external reagent or amplification for detection. The technology has been used to detect Haemophilus influenzae DNA in nasopharyngeal swabs with 100% sensitivity and 99% accuracy.
Fluorescence PCR:
Fluorescence Polymerase Chain Reaction (PCR) is a technique that involves the use of fluorescent dyes to amplify a specific segment of DNA. The process is widely used in molecular diagnostics for the detection and identification of infectious diseases such as HIV, Hepatitis B & C, influenza, Herpes Simplex virus 1 & 2 and H. influenzae among others.
Application Insights:
Based on the application, the global market is segmented into hospital and clinic. The hospital application segment dominated the overall market in terms of revenue in 2017. This is due to a rise in number of patients with respiratory tract infections and an increase in prevalence of target pathogens such as H1N1, H3N2, and others that require rapid diagnosis for effective management. In addition, an increase in investment by government bodies for development of diagnostic tests that are simple, sensitive and specific will further boost product demand over the forecast period.
The clinic application segment will witness significant growth during the forecast period owing to rising awareness about availability of advanced diagnostics methods particularly among individuals having chronic diseases or surgeries at risk of developing complications related to pneumonia infection such as asthma or COPD which may require early intervention with regard to treatment procedures thus driving demand globally over next seven years.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the higher disease burden, better healthcare facilities, and a high level of awareness pertaining to early diagnosis. Moreover, government initiatives such as Haemophilus Conjugate Vaccine Program (HCV) and National Immunization Program are expected to boost product demand over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising disposable income coupled with increasing population base in countries like India and China. Furthermore, improving healthcare infrastructure is also likely to support regional growth over the next eight years.
The presence of a large number of players in Europe has led this region into second position after North America for generating revenue through HAI testing products sale globally in 2017).
Growth Factors:
- Increasing incidence of Haemophilus influenzae infections: The increasing incidence of Haemophilus influenzae infections is one of the major growth drivers for the haemophilus nucleic acid detection kit market. H. influenzae is a leading cause of bacterial meningitis and sepsis in children and adults in developed countries. According to the Centers for Disease Control and Prevention (CDC), H. influenzae accounts for about 10%–15% of all cases of meningitis in the U.S., making it the second most common cause after Streptococcus pneumoniae
- Rising demand for rapid diagnosis: The rising demand for rapid diagnosis is another key growth driver for the haemophilus nucleic acid detection kit market, as early diagnosis can help reduce morbidity and mortality rates associated with H. influenzae infections significantly
Scope Of The Report
Report Attributes
Report Details
Report Title
Haemophilus Influenzae Nucleic Acid Detection Kit Market Research Report
By Type
Dry PCR, Fluorescence PCR
By Application
Hospital, Clinic
By Companies
BioGerm, Geneodx, Sansure, Bioperfectus, Kinghawk
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
234
Number of Tables & Figures
164
Customization Available
Yes, the report can be customized as per your need.
Global Haemophilus Influenzae Nucleic Acid Detection Kit Market Report Segments:
The global Haemophilus Influenzae Nucleic Acid Detection Kit market is segmented on the basis of:
Types
Dry PCR, Fluorescence PCR
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- BioGerm
- Geneodx
- Sansure
- Bioperfectus
- Kinghawk
Highlights of The Haemophilus Influenzae Nucleic Acid Detection Kit Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Dry PCR
- Fluorescence PCR
- By Application:
- Hospital
- Clinic
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Haemophilus Influenzae Nucleic Acid Detection Kit Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
The Haemophilus Influenzae Nucleic Acid Detection Kit is a diagnostic tool used to detect the presence of H. influenzae nucleic acid in samples.
Some of the key players operating in the haemophilus influenzae nucleic acid detection kit market are BioGerm, Geneodx, Sansure, Bioperfectus, Kinghawk.
The haemophilus influenzae nucleic acid detection kit market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Haemophilus Influenzae Nucleic Acid Detection Kit Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Haemophilus Influenzae Nucleic Acid Detection Kit Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Haemophilus Influenzae Nucleic Acid Detection Kit Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Haemophilus Influenzae Nucleic Acid Detection Kit Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Haemophilus Influenzae Nucleic Acid Detection Kit Market Size & Forecast, 2020-2028
4.5.1 Haemophilus Influenzae Nucleic Acid Detection Kit Market Size and Y-o-Y Growth
4.5.2 Haemophilus Influenzae Nucleic Acid Detection Kit Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Dry PCR
5.2.2 Fluorescence PCR
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Haemophilus Influenzae Nucleic Acid Detection Kit Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Haemophilus Influenzae Nucleic Acid Detection Kit Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Dry PCR
9.6.2 Fluorescence PCR
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Dry PCR
10.6.2 Fluorescence PCR
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Dry PCR
11.6.2 Fluorescence PCR
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Dry PCR
12.6.2 Fluorescence PCR
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Dry PCR
13.6.2 Fluorescence PCR
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Haemophilus Influenzae Nucleic Acid Detection Kit Market: Competitive Dashboard
14.2 Global Haemophilus Influenzae Nucleic Acid Detection Kit Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 BioGerm
14.3.2 Geneodx
14.3.3 Sansure
14.3.4 Bioperfectus
14.3.5 Kinghawk
